The Controlled Human Infection Model for Enterotoxigenic Escherichia coli

Chad K Porter¹, Kawsar R Talaat², Sandra D Isidean^{3

4}, Alwine Kardinaal⁵, Subhra Chakraborty⁶, Ramiro L Gutiérrez³, David A Sack⁶, A Louis Bourgeois⁷

Affiliations

¹ Enteric Diseases Department, Naval Medical Research Center, Silver Spring, MD, 20910, USA. chad.k.porter2.civ@mail.mil.
² Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Baltimore, MD, 21205, USA.
³ Enteric Diseases Department, Naval Medical Research Center, Silver Spring, MD, 20910, USA.
⁴ Henry M. Jackson Foundation, Bethesda, MD, 20817, USA.
⁵ NIZO Food Research, Ede, P.O. Box 20, 6710 BA EDE, Kernhemseweg 2, 6718 ZB EDE, The Netherlands.
⁶ Department of International Health, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Baltimore, MD, 21205, USA.
⁷ PATH|Center for Vaccine Innovation and Access, 455 Massachusetts Avenue NW, Suite 1000, Washington, DC, 20001, USA.

PMID: 34669040
DOI: 10.1007/82_2021_242

Review

The Controlled Human Infection Model for Enterotoxigenic Escherichia coli

Chad K Porter et al. Curr Top Microbiol Immunol. 2024.

. 2024:445:189-228.

doi: 10.1007/82_2021_242.

Authors

Chad K Porter¹, Kawsar R Talaat², Sandra D Isidean^{3

4}, Alwine Kardinaal⁵, Subhra Chakraborty⁶, Ramiro L Gutiérrez³, David A Sack⁶, A Louis Bourgeois⁷

Affiliations

¹ Enteric Diseases Department, Naval Medical Research Center, Silver Spring, MD, 20910, USA. chad.k.porter2.civ@mail.mil.
² Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Baltimore, MD, 21205, USA.
³ Enteric Diseases Department, Naval Medical Research Center, Silver Spring, MD, 20910, USA.
⁴ Henry M. Jackson Foundation, Bethesda, MD, 20817, USA.
⁵ NIZO Food Research, Ede, P.O. Box 20, 6710 BA EDE, Kernhemseweg 2, 6718 ZB EDE, The Netherlands.
⁶ Department of International Health, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Baltimore, MD, 21205, USA.
⁷ PATH|Center for Vaccine Innovation and Access, 455 Massachusetts Avenue NW, Suite 1000, Washington, DC, 20001, USA.

PMID: 34669040
DOI: 10.1007/82_2021_242

Abstract

The controlled human infection model (CHIM) for enterotoxigenic Escherichia coli (ETEC) has been instrumental in defining ETEC as a causative agent of acute watery diarrhea, providing insights into disease pathogenesis and resistance to illness, and enabling preliminary efficacy evaluations for numerous products including vaccines, immunoprophylactics, and drugs. Over a dozen strains have been evaluated to date, with a spectrum of clinical signs and symptoms that appear to replicate the clinical illness seen with naturally occurring ETEC. Recent advancements in the ETEC CHIM have enhanced the characterization of clinical, immunological, and microbiological outcomes. It is anticipated that omics-based technologies applied to ETEC CHIMs will continue to broaden our understanding of host-pathogen interactions and facilitate the development of primary and secondary prevention strategies.

Keywords: CHIM; Clinical trial; Controlled human infection model; Diarrhea; Enterotoxigenic Escherichia coli; ETEC; Experimental infection; Travelers’ diarrhea; Vaccine.

PubMed Disclaimer

References

1. Aase A et al (2015) Salivary IgA from the sublingual compartment as a novel noninvasive proxy for intestinal immune induction. Mucosal Immunol
1. Academy of Medical Sciences (2005) Microbial Challenge Studies of Human Volunteers, a guidance document
1. Adachi JA et al (2003) Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico. Clin Infect Dis 37(9):1165–1171 - PubMed - DOI
1. Ahmed T et al (2009) Children with the Le(a+b-) blood group have increased susceptibility to diarrhea caused by enterotoxigenic Escherichia coli expressing colonization factor I group fimbriae. Infect Immun 77(5):2059–2064 - PubMed - PMC - DOI
1. Alam MM et al (2014) Antigen-specific memory B-cell responses to enterotoxigenic Escherichia coli infection in Bangladeshi adults. PLoS Negl Trop Dis 8(4):e2822

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Springer
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The Controlled Human Infection Model for Enterotoxigenic Escherichia coli

Affiliations

The Controlled Human Infection Model for Enterotoxigenic Escherichia coli

Authors

Affiliations

Abstract

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical